石蜡相变微胶囊的制备与表征

采用复乳交联法制备了以相变石蜡为芯材、壳聚糖为壁材的新型储能相变微胶囊。 此相变微胶囊具有很高的相变焓值（可达110 J/g以上）,并且可以根据具体需要改变芯材的温度;TGA研究表明,该相变微胶囊具有很好的热稳定性,在150 ℃以下可以稳定存在;由于壳材料进行了化学交联反应,使得该相变微胶囊具有很好溶剂稳定性,可以在水、乙醇和乙醚等常见溶剂中稳定存在。     

硬脂酸丁酯微胶囊的制备与表征

采用原位聚合法用脲醛树脂包覆硬脂酸丁酯,制得相变储热微胶囊.利用激光粒径分布仪、扫描电镜、差示扫描量热仪(DSC)和傅立叶转换红外光谱仪分别研究了微胶囊的粒径分布、表面形态、热性能和壳结构.结果表明,所得微胶囊粒径分布均匀,表面光洁,具有良好的韧性和致密性.不同的制备工艺对微胶囊粒径分布有一定的影响,其中在28 000 r/m in下乳化5 m in时,所得微胶囊的粒径分布集中在1~4μm.DSC测定结果显示硬脂酸丁酯微胶囊的最大相变焓为68 J/g.     

热敏显色微胶囊的制备与表征

热敏显色微胶囊是用于传真、条形码系统、医用图像、各种打印等领域的重要材料,它是一种内部含有染料隐色体的球形胶囊。染料隐色体是一种内酯结构的无色染料,在一定条件下,与显色剂发生显色反应。由于染料隐色体的化学惰性不够理想,易受外界因素的干扰,因而在应用中受到一定限制,所以为了克服其存在的不足,常将其微胶囊化。微胶囊的芯壁结构可以将芯材与外界隔离,提高芯材的稳定性,同时保留芯材原有的化学性质。当环境温度在微胶囊的玻璃化温度以上时,由于形成微胶囊壁的物质透过性显著增加,因此显色成分接触而发生显色反应。本文利用界面聚合法,以聚乙烯醇为保护胶体,曲拉通X-100为表面活性剂,聚氨酯为壁材,染料隐色体为芯材,合成了聚氨酯热敏显色微胶囊。研究了三个主要因素对微胶囊的粒径及其分布、表面形貌和热敏显色性能的影响。结果表明,增大保护胶体浓度,提高乳化速度,增加乳化剂用量,微胶囊的平均粒径变小,粒径分布变窄,表面变得光滑而且致密,具有较高的热敏显色密度。利用红外光谱仪确认了微胶囊的结构,在最优条件下,所制备的微胶囊玻璃化温度为131 ℃,并具有良好的热稳定性。     

纳米金掺杂中空微胶囊的制备与表征

将表面含有双键的二氧化硅微粒分散在纳米金和聚乙烯吡咯烷酮溶液中.在此溶液中以聚乙烯吡咯烷酮为模板聚合物进行丙烯酸的模板聚合,得到二氧化硅为核、聚丙烯酸/聚乙烯吡咯烷酮/纳米金为壳层的核壳结构微粒.用氢氟酸将二氧化硅微粒去除后,得到了纳米金粒子掺杂的微胶囊.分别用扫描电子显微镜和激光共聚焦显微镜表征了微胶囊在干态和湿态下的形貌.通过电子衍射和透射电子显微镜确证了纳米金粒子在微囊壁上的存在和分布.     

有机颜料酞菁蓝微胶囊的原位微悬浮法制备及其表征

通过简单的超声分散及强力剪切将滤饼中的有机颜料颗粒以初级粒子形式均匀稳定地分散到单体分散液和微悬浮液中的单体小液滴内,经有机颜料单体分散液的预聚处理和原位微悬浮聚合制备得到一系列具有高颜料包裹率和窄粒径分布特点的微米级聚合物胶粒.实验观察和粒径分析DLS证明,预聚处理可明显提高微悬浮体系中单体液滴相的黏度,因而可有效改...     

胆甾相液晶微胶囊制备与表征

为了实现液晶的分散和保护,开展了胆甾相液晶的包覆研究。通过扫描电镜和激光粒度仪等分析手段探究了液晶微胶囊的形貌及粒径分布范围,利用傅里叶变换红外光谱确认了液晶微胶囊的组成,通过偏光显微镜研究液晶微胶囊在加热前后的光学特性。当原料投入比为5∶4、剪切速率为7000r/min、剪切时间为10min、乳化剂HSMA用量为5mL时,所制备胆甾相液晶微胶囊具有单分散性好、显色性优、耐高温能力强等优点,可以制成热致变色液晶膜。     

苯乙醛纳米微胶囊的制备及特性表征

苯乙醛是一种常用的香料,但其在空气中易变质,为提高其稳定性,本实验以苯乙醛为芯材、海藻酸钠为壁材制备纳米微胶囊,以纳米微胶囊粒径为指标,通过单因素实验与响应面分析法对壁材用量、香精用量和乳化剂用量等因素进行优化。然后采用激光粒度分析仪、扫描电子显微镜、热重分析仪对纳米微胶囊进行表征。结果表明:(1)最佳的制备条件:乳化剂为吐温80,海藻酸钠浓度为0.561 mg·mL^-1,香精添加量为0.251%,乳化剂添加量为0.076%,在此条件下制备出的纳米微胶囊粒径约为150 nm。(2)通过对比苯乙醛、海藻酸钠、纳米微胶囊三者的红外光谱图分析可知,苯乙醛纳米微胶囊包埋成功。(3)纳米微胶囊扫描电镜结果显示,干燥后的纳米微胶囊形状近似椭圆形或不规则球形,粒径大多数分布在200 nm以下。(4)通过热稳定性分析可知,纳米微胶囊在能够延缓苯乙醛的释放速率,延长留香时间。     

大豆分离蛋白-十二烷基硫酸钠微胶囊的制备与表征

以大豆分离蛋白(SPI)和十二烷基硫酸钠(SDS)为壁材, 以十六烷为芯材, 通过复凝聚法制备了微胶囊. 首先确定了SPI和SDS发生复凝聚的适宜pH、SPI/SDS配比、壁材浓度等. 在确定的实验条件下进行复凝聚, 凝聚物产率可达85%. 改变搅拌转速和芯壁比, 考察它们对微胶囊性能的影响. 用光学显微镜观察了微胶囊形貌. 用气相色谱测定了微胶囊的载药量和包覆率. 芯壁比为2、搅拌转速为400 r/min时所制备微胶囊的载药量可达61%. 随着芯壁比的增大, 微胶囊粒径及载药量都逐渐增大.     

具有薄荷香味的相变微胶囊的制备与表征

利用界面聚合法,以异佛尔酮二异氰酸酯与己二胺为单体聚合形成的聚脲为外壳,以正十八烷、薄荷素油的混合物为芯材,制备了具有薄荷香味的相变微胶囊。利用光学显微镜、扫描电镜、红外光谱仪、差示扫描量热仪、热重分析仪等对微胶囊的形貌、化学结构和热性能进行了表征。结果表明:制备的微胶囊为球形,平均粒径约7.0μm,有较高的储热能力和较好的热稳定性;芯材中添加8.3%的正十四醇或高熔点石蜡,可很好地抑制相变微胶囊的过冷现象。     

包覆酞菁蓝电泳液的脲醛树脂微胶囊的制备与表征

采用重结晶的方法纯化并超细化酞菁蓝,得到粒径为200～500 nm的超细化酞菁蓝晶体.通过表面改性的方法提高了酞菁蓝在四氯乙烯中的悬浮性能,得到了稳定的酞菁蓝电泳液.以脲醛树脂为壁材,电泳液为囊芯,采用“一步法”原位聚合制备了蓝色电子墨水微胶囊.扫描电子显微镜(SEM)照片表明,制得的微胶囊粒径为30～50 μm,球形规整,表面光滑.研究了影响微胶囊制备的关键因素,最佳的微胶囊制备条件为:聚乙烯醇和尿素的质量比为0.20,反应时间为3～4h,pH为3～4,搅拌速率为500～700 r/min.     

新型聚乙烯醇微囊的制备及其结构性能研究

采用低温物理交联法制备新型聚乙烯醇微囊,所得微囊机械强度好,克服了目前普遍采用的海藻酸钠-聚赖氨酸-海藻酸钠(APA)微囊易碎的缺点,在APA微囊已完全破碎的机械强度下,聚乙烯醇微囊的破碎率仅为3%.在体外模拟肠胃生理极限条件下可保持稳定的物理化学性质,对尿素、尿酸和肌酐等小分子具有良好的通透性,能在10min内完全通透.将高效分解尿素的脲酶基因工程菌E.coliDH5包埋于聚乙烯醇微囊之中,其工程菌仍具有很高的分解尿素能力,其活力约为自由菌的80%.     

聚磷酸铵-苯并噁嗪微胶囊的制备及其对环氧树脂燃烧性能影响

以多聚甲醛、丙烯胺、苯酚为原料,通过Mannich反应合成烯丙基型苯并噁嗪单体(Bala),并通过核磁共振氢谱(~1H-NMR)确定了其化学结构.将Bala在聚磷酸铵(APP)原位开环聚合后,制备APP微胶囊(BMAPP).傅里叶变换红外(FTIR)和静态接触角测试表明,Bala在APP表面成功聚合,并有效提高APP的疏水性,与纯APP相比,BMAPP的接触角从10.8°提高到了71.3°.将BMAPP添加到环氧树脂(EP)中,制备EP/BMAPP复合材料.通过热重分析仪(TGA)、垂直燃烧(UL-94)、极限氧指数(LOI)、锥型量热仪(CONE)和动态热机械分析仪(DMA)对EP和EP/BMAPP的热性能以及燃烧性能进行对比分析.结果显示,10%的BMAPP的成炭效果最佳,有良好的阻燃性能,可使EP的LOI值从22.6%提高到33.6%,并通过UL-94 V-0级,600°C下残炭率达26.3%.同时,BMAPP可大幅度降低EP燃烧过程中烟密度和热释放速率,提高EP的玻璃化转变温度(T_g).BMAPP/EP-10%中,PBala和APP协同后使EP热释放速率峰值(PHRR)由1247 kW·m~(-2)降低到434 kW·m~(-2),生烟速率(SPR)降低67%左右,T_g从169°C提高到了173°C.     

甲胺基阿维菌素苯甲酸盐微胶囊的制备与表征

以三聚氰胺-甲醛树脂为壁材,采用原位聚合法制备了甲胺基阿维菌素苯甲酸盐微胶囊,研究了三聚氰胺与甲醛的质量比、芯壁比、乳化剂、搅拌速度与时间、pH值、温度等因素对微胶囊形成的影响,对制备的微胶囊进行了表征,测定了甲维盐微胶囊化前后的光解率。结果表明,三聚氰胺与甲醛质量比为1∶2、芯材与壁材质量比为3∶2、以质量分数1%羟乙基纤维素(HEC)为乳化剂、在1000r/min搅拌速度下、pH=5.0和50℃保温2h可制备出形貌较好、平均粒径4.4μm的甲维盐微胶囊。红外光谱分析证明,甲维盐已完全被包覆在微胶囊中。紫外分光光度法测定其缓释性能良好。光解实验表明,微胶囊化可有效降低甲维盐原药的光解。     

Advances in Uniform Polymer Microspheres and Microcapsules: Preparation and Biomedical Applications

Microspheres and microcapsules have been widely used in biomedical field, such as delivery systems for drugs, vaccines. Uniform particle is required for precise drug delivery and disease treatment, since the particle diameter is a key factor which controls the pharmacokinetics and efficacy of loaded drug. However, there is no universal method to prepare uniform particles either from monomer or preformed polymer raw materials. We have developed two membrane emulsification techniques (MET) to prepare uniform particles with controllable size. In this review, we introduce two MET processes and their mechanisms, and how to develop MET to different emulsion systems to obtain various uniform microspheres and microcapsules with interesting morphologies. Then, the advantages of uniform particles on biomedical application results are focused. Finally, particle design and applications as “Chassis” to form synthetic vaccine are described. What is the most favorite and original chemistry developed in your research group? We clarified the mechanism for obtaining uniform microspheres and microcapsules in O/W, W/O and double emulsion systems, which enabled us to develop the technique to a universal technique, successfully preparing various uniform particles including hydrophobic, hydrophilic and composite functional particles, and leading to the original systematic studies on biomedical applications including “Synthetic Vaccine”. How do you get into this specific field? Could you please share some experiences with our readers? I started the research on preparation of nanospheres from my master course. At that time, I knew there were few universal methods to obtain uniform microspheres and microcapsules. So, after I became an assistant professor, I began to consider this scientific topic. How do you supervise your students? Our group motto is “Enjoy Science, Enjoy Work, Enjoy Life”. I tried to lead the students to like their research, and tried to find interesting results with students together based on their primary experimental results. What is the most important personality for scientific research? Pure, Passion, Perseverance. How do you keep balance between research and family? Work hard, and let my family know I am enjoyable and happy with my research, getting support and encouragement from family. Who influences you mostly in your life? My father. He always read books at the desk. He always gave me encouragement no matter happy or sad.     

Preparation and Characterization of Microcapsules for Self-healing Materials

The urea-formaldehyde(UF) capsules filled with a healing agent, a mixture of epoxy resins(epoxy 711 and E-51) as core material, were produced by means of one step in-situ polymerization. The characteristics of these microcapsules were studied via scanning electron microscopy(SEM), particle size analysis, FTIR and DSC/TGA. The results show that the dispersed and integrated microcapsules of 5 μm in shell thickness were synthesized successfully. The capsules were produced with diameters ranging from 10 to 250 μm via controlling agitation rate. Young’s modulus of the capsule was a little lower than those of the epoxy resins, but the microcapsules having such a shell thickness were robust enough to survive handling during manufacturing self-healing composites. When damage occurred in the epoxy matrix, the crack could rupture the microcapsule to make the repairing agent release.     

单细胞成像分析研究进展

本文综述了近年来单细胞成像分析方法的研究进展。重点讨论了图像细胞光度测量、荧光显微成像、红外(近红外)与拉曼显微成像、磁共振成像和扫描探针显微镜成像等技术,并展望了单细胞成像的发展前景。     

微胶囊膜表面化学组成的XPS分析

采用XPS表面表征技术对生物微胶囊膜表面化学组成进行了分析。结果表明,海藻酸钠_壳聚糖_海藻酸钠(ACA)微胶囊表面带负电荷的含C基团与带正电荷的含N基团的相对百分含量分别为30·6%与60·4%,而海藻酸钠_聚赖氨酸_海藻酸钠(APA)微胶囊分别为42·3%与30·0%,因此ACA微胶囊表面比APA微胶囊带更多的正电荷,更有利于蛋白质吸附与细胞粘附。为深入了解生物微胶囊表面引起的机体反应过程、改进微胶囊性能,提供了理论依据。